Intersect ENT, Inc.

Intersect ENT (NASDAQ: XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients.Intersect ENT’s initial focus is on improving the treatment of chronic sinusitis, an inflammatory condition that affects one out of eight adults in the U.S. and has a greater impact on quality of life than congestive heart failure or chronic back pain.

Bank Name Intersect ENT, Inc.
Stock Exchange NASDAQ
Symbol XENT
Sector Healthcare
Industry Medical/Dental Instruments
Country United States
World Region Amarica
CEO Ms. Lisa D. Earnhardt
Employees 327
Registered Year 2003